UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):November 14, 2014
REVOLUTIONS MEDICAL CORPORATION |
(Exact name of registrant as specified in its charter) |
Nevada |
| 000-28629 |
| 73-1526138 |
(State or other jurisdiction of incorporation) |
| (Commission File Number) |
| (IRS Employer Identification No.) |
| 1124 Park West Blvd. Suite #102 Mount Pleasant, SC 29466 |
|
| (Address of Principal Executive Offices) |
|
(843) 971-4848
Registrant’s telephone number, including area code
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01Other Events.
On November 14, 2014, Revolutions Medical Corporation (the “Company”) filed a Quarterly Report on Form 10-Q for the three months ended on September 30, 2014, in which the Company stated that KBM Worldwide Inc. (“KBM”) is an affiliate of Asher Enterprises, Inc. (“Asher”). The Company hereby amends such statement and clarifies that KBM and Asher are neither related parties nor affiliation of each other.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| REVOLUTIONS MEDICAL CORPORATION | |
|
|
|
Date: November 19, 2014 | By: | /s/ Rondald L. Wheet |
|
| Rondald L. Wheet |
|
| Chief Executive Officer |
|
|
|
